A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting Response.

Pharmaceuticals (Basel) · 2023 · PMC10385131 · PMID 37513846

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

[ 55 ], super-responders (with ≥75% reduction in MHDs) were more likely to have unilateral pain than non-responders (≤25% reduction in MHDs), although the difference did not reach statistical significance (crude OR: 4.51, 95% CI: 0.72–28.32).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.